Esperela, Fe A.

HRN: 22-14-76  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2025
CEFTRIAXONE 1G (VIAL)
07/28/2025
08/03/2025
IVTT
2g
Once A Day
CAP-MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines